Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 19 or older
- People who are able to give their own informed consent to take part in the study
- People who have suspected, newly diagnosed, or established depression — or who are experiencing a first episode of psychosis, or have suspected or established schizophrenia
- People who, in the investigator's opinion, are likely to be able to complete standardised mental health questionnaires at each study visit
Who may not be able to join:
- People who are unable to give informed consent to participate
- People who are currently enrolled in another research study involving drugs or devices that could affect mental health treatment outcomes
- People who are currently on extended leave under British Columbia's Mental Health Act
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Steven Reynolds, MD, FRCPC, Royal Columbian Hospital Foundation
Phone: +1 (236) 332-6575
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Relationship between Depression and Biomarker Characteristics; Relationship between Psychotic Disorders and Biomarker Characteristics
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.